G66C (p.Gly66Cys) variant of KRT9 (Keratin, type I cytoskeletal 9)

G66C (p.Gly66Cys) in KRT9 (Keratin, type I cytoskeletal 9) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes population frequency data and structural context.

G66C (p.Gly66Cys) variant details